What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Safety warnings
|
Blood & Tissue
|
01/08/2024
The Federal Office for Safety in Health Care was informed of two confirmed autochthonous WNV cases in the northern and southern parts of the Vienna environs.
Buprenorphine (all formulations except implants) New
PSUR-outcome
|
31/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Teriflunomide New
PSUR-outcome
|
31/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Leflunomide New
PSUR-outcome
|
29/07/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Safety warnings
|
Blood & Tissue
|
29/07/2024
The Federal Office for Safety in Health Care (BASG) has been informed by the French authorities that a human WNV infection has been recorded in France, in the Var department of the Provence Alpes Côte d'Azur region.
Levofloxacin (i.v. and oral use) New
PSUR-outcome
|
23/07/2024
Further information and amendments to the product information can be found on the EMA website.
Baclofen (oral, for muscle spasticity indication) New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.
Acitretin New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.
Diclofenac (topical formulations) New
PSUR-outcome
|
17/07/2024
Further information and amendments to the product information can be found on the EMA website.
Safety warnings
|
Blood & Tissue
|
30/04/2024
The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Center for Disease Prevention and Control) that a human WNV infection has been recorded in Seville, in the region of Andalusia.